Empagliflozin alleviates diabetes-induced cognitive impairments by lowering nicotinamide adenine dinucleotide phosphate oxidase-4 expression and potentiating the antioxidant defense system in brain tissue of diabetic rats
Habib Yaribeygi, Mohammad Amin Hemmati, Fatemeh Sokouti Nasimi, Roghayeh Pakdel, Tannaz Jamialahmadi, Amirhossein Sahebkar
Topics & Concepts
Nicotinamide adenine dinucleotide phosphateEmpagliflozinNicotinamide adenine dinucleotideDiabetes mellitusAntioxidantChemistryPharmacologyBrain tissueOxidase testNeuroscienceEndocrinologyBiochemistryMedicineInternal medicineEnzymePsychologyType 2 diabetesNAD+ kinaseNeurological Disease Mechanisms and TreatmentsRetinal Diseases and TreatmentsNeurological Disorders and Treatments